Research into conolidine has brought about discovery of an opioid receptor in the body known as ACKR3/CXCR7. ACKR3 is apparently by far the most desired target for conolidine, which also disregards the opposite four classical opioid receptors(3). Advancements while in the idea of the cellular and molecular mechanisms of https://bookmarkcolumn.com/story20626767/fascination-about-conolidin-to-replace-traditional-painkillers